MARIA PRUDHOMME: Open Payments
NPI 1710396718 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$851 in 33 payments from 11 companies in 2025. Trend: 2023 $1,332 · 2024 $749 · 2025 $851
Food & beverage: $756Education: $95
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $353 |
| Novartis Pharmaceuticals Corporation | 9 | $172 |
| Janssen Biotech, Inc. | 2 | $111 |
| GENZYME CORPORATION | 2 | $43 |
| Incyte Corporation | 2 | $40 |
| UCB, Inc. | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Organon LLC | 3 | $22 |
| Lilly USA, LLC | 1 | $19 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
Products named: NEMLUVIO, COSENTYX, TREMFYA, DUPIXENT, OPZELURA, Bimzelx, LIBTAYO, TALTZ.
Industry payments across OK — which companies pay providers there.
